Clinical Research
Atrial Fibrillation
Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial Fibrillation

https://doi.org/10.1016/j.jacc.2006.08.060Get rights and content
Under an Elsevier user license
open archive

Objectives

This study sought to identify whether obesity and obstructive sleep apnea (OSA) independently predict incident atrial fibrillation/flutter (AF).

Background

Obesity is a risk factor for AF, and OSA is highly prevalent in obesity. Obstructive sleep apnea is associated with AF, but it is unknown whether OSA predicts new-onset AF independently of obesity.

Methods

We conducted a retrospective cohort study of 3,542 Olmsted County adults without past or current AF who were referred for an initial diagnostic polysomnogram from 1987 to 2003. New-onset AF was assessed and confirmed by electrocardiography during a mean follow-up of 4.7 years.

Results

Incident AF occurred in 133 subjects (cumulative probability 14%, 95% confidence interval [CI] 9% to 19%). Univariate predictors of AF were age, male gender, hypertension, coronary artery disease, heart failure, smoking, body mass index, OSA (hazard ratio 2.18, 95% CI 1.34 to 3.54) and multiple measures of OSA severity. In subjects <65 years old, independent predictors of incident AF were age, male gender, coronary artery disease, body mass index (per 1 kg/m2, hazard ratio 1.07, 95% CI 1.05 to 1.10), and the decrease in nocturnal oxygen saturation (per 0.5 U log change, hazard ratio 3.29, 95% CI 1.35 to 8.04). Heart failure, but neither obesity nor OSA, predicted incident AF in subjects ≥65 years of age.

Conclusions

Obesity and the magnitude of nocturnal oxygen desaturation, which is an important pathophysiological consequence of OSA, are independent risk factors for incident AF in individuals <65 years of age.

Abbreviations and Acronyms

AF
atrial fibrillation/flutter
CI
confidence interval
HR
hazard ratio
OSA
obstructive sleep apnea

Cited by (0)

The authors are funded by NIH grants HL61560, HL65176, HL73211, and M01-RR00585, and the Mayo Clinic.

1

Dr. Somers is a consultant for Respironics, co-investigator for a study funded with a grant from ResMed Foundation, and has received an honorarium from ResMed.